Kuros Biosciences (CSBTF) Q2 2025 Earnings Report
CSBTF Q2 2025 EPS Results
- Actual EPS
- -$0.05
- Consensus EPS
- ―
- Beat/Miss
- ―
- One Year Ago EPS
- -$0.01
CSBTF Q2 2025 Revenue Results
- Actual Revenue
- $66.15M
- Expected Revenue
- $33.03M
- Beat/Miss
- Beat by +$33.12M
- YoY Revenue Growth
- +71.87%
Earnings Announcement Details
- Quarter
- Q2 2025
- Date
- 08/14/2025
- Time
- Before Open
- Conference Call
- Thursday, August 14, 2025
CSBTF Upcoming Earnings
Kuros Biosciences's next earnings date is estimated for March 3, 2027, based on past reporting schedules.
Q2 2025 Earnings Call Audio
CSBTF Q2 2025 Earnings Call
0:00 / 0:00
Q2 2025 Earnings Slide Deck
Q2 2025 Earnings Call Summary
No earnings call summary is available for this earnings event.
CSBTF Earnings History
| Report Date | Fiscal Quarter | Forecast / EPS | Last Year's EPS | EPS YoY Change | Press Release |
|---|---|---|---|---|---|
| Mar 03, 2027 | 2026 (Q4) | 0.10- | 0.11 | ― | ― |
| Aug 13, 2026 | 2026 (Q2) | 0.070.07 | -0.04 | 262.22% (+0.12) | |
| Mar 10, 2026 | 2025 (Q4) | 0.000.11 | -0.13 | 184.55% (+0.25) | |
| Aug 14, 2025 | 2025 (Q2) | ―-0.05 | -0.01 | -650.00% (-0.05) | |
| Mar 11, 2025 | 2024 (Q4) | ―-0.13 | -0.29 | 53.59% (+0.15) | |
| Aug 08, 2024 | 2024 (Q2) | ―-0.01 | -0.17 | 95.65% (+0.16) | |
| Mar 13, 2024 | 2023 (Q4) | ―-0.29 | -0.38 | 25.47% (+0.10) | |
| Aug 09, 2023 | 2023 (Q2) | ―-0.17 | -0.14 | -22.12% (-0.03) | |
| Mar 15, 2023 | 2022 (Q4) | ―-0.38 | -0.27 | -40.09% (-0.11) | |
| Aug 09, 2022 | 2022 (Q2) | ―-0.14 | 0 | -3666.67% (-0.13) |
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat Missed
